Sejal Patel, Maroeska M Rovers, Michiel J P Sedelaar, Petra L M Zusterzeel, Ad F T M Verhagen, Camiel Rosman, Janneke P C Grutters
{"title":"How can robot-assisted surgery provide value for money?","authors":"Sejal Patel, Maroeska M Rovers, Michiel J P Sedelaar, Petra L M Zusterzeel, Ad F T M Verhagen, Camiel Rosman, Janneke P C Grutters","doi":"10.1136/bmjsit-2020-000042","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To develop an interactive tool that estimates what potential benefits are needed for the robot to provide value for money when compared with endoscopic or open surgical interventions.</p><p><strong>Design: </strong>A generic online interactive tool was developed to analyze the (health) effects needed to compensate for the additional costs of using a surgical robotic system from a healthcare perspective. The application of the tool is illustrated with a hypothetical new surgical robotic platform. A synthesis of evidence from different sources was used combined with interviews with surgeons.</p><p><strong>Setting: </strong>Flexible tool that can be adapted to flexible settings.</p><p><strong>Participants: </strong>Any hospital patient group for which robotic, endoscopic or open surgical procedures may be considered as appropriate treatment alternatives (eg, urology, gynecology, and so on).</p><p><strong>Intervention: </strong>Robotically assisted surgical interventions.</p><p><strong>Comparator: </strong>Endoscopic or open surgical interventions.</p><p><strong>Main outcome measures: </strong>Thresholds of how much (health) effect is needed for robot-assisted surgery to provide value for money and to become cost-effective.</p><p><strong>Results: </strong>The utilization rate of the surgical robotic system and a reduction in complications appeared to be important aspects in determining the value for money. To become cost-effective, it was deemed important for new surgical robotic systems to have added clinical benefit and become less costly than the current system.</p><p><strong>Conclusions: </strong>This paper and its assisting interactive tool can be used by clinicians, researchers, and policymakers to gain insight in the benefit needed to provide value for money when using a (new) surgical robotic system or, when the effects are known or can be estimated, to assess the value for money for a specific indication. For robotic surgery to provide most value for money, we recommend assessing for each indication whether the necessary effects seem achievable.</p>","PeriodicalId":33349,"journal":{"name":"BMJ Surgery Interventions Health Technologies","volume":"3 1","pages":"e000042"},"PeriodicalIF":2.1000,"publicationDate":"2021-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/bmjsit-2020-000042","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Surgery Interventions Health Technologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjsit-2020-000042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 4
Abstract
Objectives: To develop an interactive tool that estimates what potential benefits are needed for the robot to provide value for money when compared with endoscopic or open surgical interventions.
Design: A generic online interactive tool was developed to analyze the (health) effects needed to compensate for the additional costs of using a surgical robotic system from a healthcare perspective. The application of the tool is illustrated with a hypothetical new surgical robotic platform. A synthesis of evidence from different sources was used combined with interviews with surgeons.
Setting: Flexible tool that can be adapted to flexible settings.
Participants: Any hospital patient group for which robotic, endoscopic or open surgical procedures may be considered as appropriate treatment alternatives (eg, urology, gynecology, and so on).
Comparator: Endoscopic or open surgical interventions.
Main outcome measures: Thresholds of how much (health) effect is needed for robot-assisted surgery to provide value for money and to become cost-effective.
Results: The utilization rate of the surgical robotic system and a reduction in complications appeared to be important aspects in determining the value for money. To become cost-effective, it was deemed important for new surgical robotic systems to have added clinical benefit and become less costly than the current system.
Conclusions: This paper and its assisting interactive tool can be used by clinicians, researchers, and policymakers to gain insight in the benefit needed to provide value for money when using a (new) surgical robotic system or, when the effects are known or can be estimated, to assess the value for money for a specific indication. For robotic surgery to provide most value for money, we recommend assessing for each indication whether the necessary effects seem achievable.